The global paroxetine market is experiencing steady growth, reaching $179 million in 2025 and projected to expand at a CAGR of 4.4% through 2033. Driven by increasing mental health awareness and the drug's efficacy in treating depression, panic disorders, and social anxiety, the market is segmented by drug type and application. Key players like Apotex and Teva shape this competitive landscape. Learn more about market trends and future projections.

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.